Literature DB >> 21222611

Identification of proteins interacting with human SP110 during the process of viral infections.

Lei Cai1, Ying Wang, Jing-Fang Wang, Kuo-Chen Chou.   

Abstract

Human SP110 plays an important role in resisting intracellular pathogens, and hence has become an important drug target for preventing intracellular pathogen diseases, such as tuberculosis, hepatic veno-occlusive disease, and intracellular cancers. Unfortunately, so far little is known about the interactions of SP110 with the other proteins in a cell, which is considered to be the key for revealing its action mechanism and mediated pathway. Using both the genetic and structural analyses as well as the segment-docking approach, we have identified two proteins: the human remodeling and spacing factor 1 (RSF1) and the activating transcription factor 7 interacting protein (ATF7IP). They are very likely interacting with human SP110 during the process of viral infections. Owing to the close relationship of RSF1 with the chromatin remodeling and ATF7IP with the chromatin formation, it is logical to infer that human SP110 may be involved in the chromatin remodeling and formation as well. These findings may provide useful insights into the development of new drugs for treating and preventing intracellular pathogen diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222611     DOI: 10.2174/157340611794859343

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  12 in total

1.  Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence.

Authors:  Isha Sengupta; Dipanwita Das; Shivaram Prasad Singh; Runu Chakravarty; Chandrima Das
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

2.  3D QSAR pharmacophore modeling, in silico screening, and density functional theory (DFT) approaches for identification of human chymase inhibitors.

Authors:  Mahreen Arooj; Sundarapandian Thangapandian; Shalini John; Swan Hwang; Jong Keun Park; Keun Woo Lee
Journal:  Int J Mol Sci       Date:  2011-12-12       Impact factor: 5.923

3.  Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method.

Authors:  Xiao-Bo Li; Shu-Qing Wang; Wei-Ren Xu; Run-Ling Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

4.  Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach.

Authors:  Ying Ma; Shu-Qing Wang; Wei-Ren Xu; Run-Ling Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

5.  iNR-Drug: predicting the interaction of drugs with nuclear receptors in cellular networking.

Authors:  Yue-Nong Fan; Xuan Xiao; Jian-Liang Min; Kuo-Chen Chou
Journal:  Int J Mol Sci       Date:  2014-03-19       Impact factor: 5.923

6.  Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone.

Authors:  Xue-Jiao Wang; Jun Zhang; Shu-Qing Wang; Wei-Ren Xu; Xian-Chao Cheng; Run-Ling Wang
Journal:  Drug Des Devel Ther       Date:  2014-11-07       Impact factor: 4.162

7.  Bioassay directed isolation and biological evaluation of compounds isolated from Rubus fairholmianus Gard.

Authors:  Blassan Plackal George; Parimelazhagan Thangaraj; Cheruthazhakkatt Sulaiman; Shanmughavel Piramanayagam; Sathish Kumar Ramaswamy
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

8.  Small molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity.

Authors:  Bing Niu; Mengying Zhang; Pu Du; Li Jiang; Rui Qin; Qiang Su; Fuxue Chen; Dongshu Du; Yilai Shu; Kuo-Chen Chou
Journal:  Oncotarget       Date:  2017-07-11

9.  Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.

Authors:  Lei Liu; Ying Ma; Run-Ling Wang; Wei-Ren Xu; Shu-Qing Wang; Kuo-Chen Chou
Journal:  Drug Des Devel Ther       Date:  2013-04-08       Impact factor: 4.162

10.  Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate.

Authors:  Juan Carlos Zapata; Ricardo Carrion; Jean L Patterson; Oswald Crasta; Yan Zhang; Sachin Mani; Marti Jett; Bhawna Poonia; Mahmoud Djavani; David M White; Igor S Lukashevich; Maria S Salvato
Journal:  PLoS Negl Trop Dis       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.